The annual CannaTech conference, one of the biggest events in the medical cannabis field, is coming back to Tel Aviv this month with a three-day summit that is expected to draw some 1,000 participants from across the world.
The yearly event highlights the latest scientific research and business developments in the field, welcoming Israeli researchers, scientists, high-tech experts, and entrepreneurs, who share their knowledge with international colleagues.
The conference will run March 31- April 2 and will include a science and business symposium, talks, panels, and an exhibition.
The event this year comes two months after the Israeli government gave its long-awaited approval for the medical cannabis export law, paving the way for the country to become a leading medical cannabis exporter and participant in a thriving sector that is expected to soar to $33 billion by 2022.
Saul Kaye, founder and CEO of CannaTech and iCAN Israel-Cannabis, said in a statement: “Since the Israeli government recently allowed medical cannabis export, interest in the nation’s unsurpassed cannabis ecosystem has dramatically increased making CannaTech Tel Aviv 2019, literally, the most important cannabis meeting place in the world.”
“Israel is at the forefront of a new global industry and together, with partners from around the world, we will help tens of millions of patients in need and I could not be prouder to showcase the advances we have made, here, in beautiful Tel Aviv,” he added.